One-Year Trial on Safety and Normal Linear Growth with Flunisolide HFA in Children with Asthma
One-Year Trial on Safety and Normal Linear Growth with Flunisolide HFA in Children with Asthma
About this item
Full title
Author / Creator
Publisher
708 Glen Cove Avenue, Glen Head, NY 11545: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
708 Glen Cove Avenue, Glen Head, NY 11545: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Flunisolide hydrofluoroalkane (HFA) has efficacy equivalent to that of flunisolide chlorofluorocarbon (CFC) at one third the dose of the CFC formulation, a reduction from 250 pg/puff for flunisolide CFC to 85 pg/puff for flunisolide HFA. Flunisolide HFA delivers a smaller particle size (1.2 pim) in solution, resulting in improved lung deposition as...
Alternative Titles
Full title
One-Year Trial on Safety and Normal Linear Growth with Flunisolide HFA in Children with Asthma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20789063
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20789063
Other Identifiers
ISSN
0009-9228
E-ISSN
1938-2707
DOI
10.1177/000992280204100506
